| Application no. and date | 15851238.4 (espacenet) (Federated) (European Patent Register), 20151014 | | Patent/reg. no. and date | DK/EP 3206692, 20240403 | | Publication date | 20170823 | | Priority no. and date | US 201462064358 P, 20141015, US 201462092041 P, 20141215 | | EP pub. no. and date |
EP 3206692 20170823 | | Effective date | | | Applicant/owner | Corcept Therapeutics Incorporated, 149 Commonwealth Drive
Menlo Park, CA 94025, US | | Applicant ref. no. | V475501DK00 | | Inventor | BELANOFF, Joseph K., 149 Commonwealth Drive
Menlo Park, California 94025, US,
HUNT, Hazel, 149 Commonwealth Drive
Menlo Park, California 94025, US,
VAN DEN HEUVEL, Jose, Leiden University Medical Center
NL-2300 RC Leiden, NL,
MEIJER, Onno C., Department of Endocrinology and
General Internal Medicine
Einthoven Laboratory
Leiden University Medical Center
P.O. Box 9600
2300 RC Leiden, NL | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/513 (2006.01) , A61P 1/16 (2006.01) | | Title | Behandling af fedtleversygdom med glucocorticoid- og mineralcorticoid-receptorantagonister | | Int. application no. | US2015055487 | | Int. publication no. | WO2016061195 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
